Actively Recruiting
Correlation and Clinical Utility of Urinary Biomarker in Membranous Glomerulonephritis
Led by Chinese University of Hong Kong · Updated on 2024-05-10
50
Participants Needed
1
Research Sites
152 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To assess the correlation of these urinary biomarkers with the serum sample and evaluated the clinical utility of using urinary sample in the detection and prognostication of MGN. Fifty patients with newly diagnosed biopsy proven MGN would be recruited and followed up for 1 years. Serum and urinary biomarkers would be collected every 4 months and their antibody titres measured with ELISA assay.
CONDITIONS
Official Title
Correlation and Clinical Utility of Urinary Biomarker in Membranous Glomerulonephritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Newly diagnosed biopsy proven primary membranous glomerulonephritis
You will not qualify if you...
- Secondary causes of membranous nephropathy, such as lupus nephritis, viral hepatitis B and C, and malignancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Medicine & Therapeutics, Prince of Wales Hospital
Shatin, Hong Kong
Actively Recruiting
Research Team
W
Winston WS Fung, MBBS
CONTACT
C
Cheuk Chun Szeto, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here